2020
DOI: 10.1016/j.biochi.2020.09.025
|View full text |Cite
|
Sign up to set email alerts
|

Stroke treatment: Is exosome therapy superior to stem cell therapy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
37
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(38 citation statements)
references
References 127 publications
1
37
0
Order By: Relevance
“…Recent studies showed promising applications of such EVs due to their cargo specificity, built on EVs’ secreted cell origin [ 196 ]. These nanovesicles can go through various biological barriers, including the blood-brain barrier; further, their cargo is well preserved and protected from degradation [ 197 ]. In comparison with stem cell therapy, EVs reduce the risk of immunogenicity, tumorigenesis, avoid cell differentiation to unexpected derivation.…”
Section: Therapeutical Application Of Extracellular Vesicles For Skin Wound Healingmentioning
confidence: 99%
“…Recent studies showed promising applications of such EVs due to their cargo specificity, built on EVs’ secreted cell origin [ 196 ]. These nanovesicles can go through various biological barriers, including the blood-brain barrier; further, their cargo is well preserved and protected from degradation [ 197 ]. In comparison with stem cell therapy, EVs reduce the risk of immunogenicity, tumorigenesis, avoid cell differentiation to unexpected derivation.…”
Section: Therapeutical Application Of Extracellular Vesicles For Skin Wound Healingmentioning
confidence: 99%
“…Recently, treatment strategies based on exosomes of MSCs have been widely reported in many diseases. The potential mechanism of exosomes treatment in the ICH mainly comprises the anti-apoptotic, neurogenesis, angiogenesis, and anti-inflammation effects through its miRNAs (Cai et al, 2020;Duan et al, 2020).…”
Section: Exosomes Therapiesmentioning
confidence: 99%
“…Finally, cell survival is not always required to achieve functional recovery of a specific organ, suggesting that a temporary paracrine effect is sufficient to stimulate endogenous regeneration in organs that retained this potency. This is shown in the case of ischemic hearts or through the action of MSCs in acute myocardial infarction, burned skins, liver or traumatic brain injuries and many other diseases [114,[131][132][133][134]. Such observations raise the question of whether cell-derived products may be sufficient for a therapeutic improvement in some specific disease conditions.…”
Section: Limitations/challengesmentioning
confidence: 99%